首页> 外文期刊>Journal of Analytical Atomic Spectrometry >Size characterization of manganese species from human serum and cerebrospinal fluid using size exclusion chromatography coupled to inductively coupled plasma mass spectrometry
【24h】

Size characterization of manganese species from human serum and cerebrospinal fluid using size exclusion chromatography coupled to inductively coupled plasma mass spectrometry

机译:尺寸排阻色谱-电感耦合等离子体质谱法测定人血清和脑脊液中锰的尺寸

获取原文
获取原文并翻译 | 示例
           

摘要

Manganese, at excess concentrations, can have adverse effects on health. Mn is a neurotoxicant. The health impacts of Mn are known mostly from occupational health studies, but the exact mechanisms by which Mn can enter the brain without transferrin-receptor mediated transport is unknown. Mn speciation at the neural barriers can help to obtain more information about the pathways and carriers. This paper therefore investigates the size distribution of Mn carriers (e.g., proteins, peptides, carbonic acids) in serum before the neural barriers and in cerebrospinal fluid behind them, as a first step in characterization of the Mn carriers involved in moving Mn across the neural barriers. Serum samples showed Mn concentrations between 1.5-2.5 μg L~(-1) (mean 1.7 ± 0.8 μg L~(-1)), the lower figure being fully in the physiological range, the higher being slightly elevated. The size distribution of Mn corresponding to the carriers showed a main peak in the transferrin/albumin size fitting to the known physiological ligands. However, preliminary results also indicated an increasing Mn peak at 700 Da with increasing total Mn concentration. This finding could point to excess Mn being transported by a low molecular mass (LMM) carrier. Samples of cerebrospinal fluid (CSF) showed Mn concentrations between 1.8-6.7 μg L~(-1) (mean 2.66 μg L~(-1), = 48 nM). Only sparse values have been published with which our results could be compared. The lower concentrations seem to be in the physiological range, whilst the higher ones are clearly elevated. In cerebrospinal fluid Mn was found to be nearly exclusively bound to LMM Mn carriers. The major fraction is in the range of 640-680 Da, which is similar to the LMM compound in serum and to Mn-citrate complexes suggested to be present in body fluids. Therefore, citrate was additionally determined in CSF. The concentration ranged from 420-713 μM (mean 573 μM), proving that citrate is in huge excess compared with Mn (ratio 1:12000). This finding makes a Mn-citrate complex in CSF likely.
机译:锰含量过高会对健康产生不利影响。 Mn是神经毒剂。锰对健康的影响主要是通过职业健康研究得知的,但是锰在没有转铁蛋白受体介导的转运的情况下进入大脑的确切机制尚不清楚。神经屏障处的锰形态可帮助获得有关途径和载体的更多信息。因此,本文研究了神经屏障之前血清中及其后脑脊液中Mn载体(例如蛋白质,肽,碳酸)的Mn分布,这是表征Mn在神经系统中移动的第一步。障碍。血清样品中的锰浓度在1.5-2.5μgL〜(-1)之间(平均1.7±0.8μgL〜(-1)),较低的数字在生理范围内,较高的略高。对应于载体的Mn的尺寸分布在与已知生理配体相符的运铁蛋白/白蛋白尺寸中显示出主峰。但是,初步结果还表明,随着总Mn浓度的增加,在700 Da处的Mn峰增加。这一发现可能表明过量的Mn被低分子量(LMM)载体运输。脑脊液(CSF)样品显示Mn浓度在1.8-6.7μgL〜(-1)之间(平均2.66μgL〜(-1)= 48 nM)。仅发布了稀疏值,可以与我们的结果进行比较。较低的浓度似乎在生理范围内,而较高的浓度则明显升高。在脑脊髓液中,发现Mn几乎完全与LMM Mn载体结合。主要部分在640-680 Da的范围内,这与血清中的LMM化合物和建议存在于体液中的柠檬酸锰复合物相似。因此,在CSF中另外测定了柠檬酸盐。浓度范围为420-713μM(平均573μM),证明与Mn(比率1:12000)相比,柠檬酸盐大大过量。这一发现使CSF中可能存在柠檬酸锰复合物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号